Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine...

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Integrin alpha IIb beta 3 plays a key role in platelet aggregation.
• Tyrosine phosphorylation is a critical signaling event regulated by integrin alpha IIb beta 3.
• Disintegrins are snake venom proteins that inhibit platelet aggregation by blocking fibrinogen binding to integrin alpha IIb beta 3.

Purpose of the Study:

• To investigate the effects of structurally distinct disintegrins on integrin-regulated tyrosine phosphorylation in platelets.
• To determine if disintegrins can activate or inhibit specific signaling pathways involved in platelet function.

Main Methods:

• Competitive inhibition of fibrinogen binding to integrin alpha IIb beta 3 using Arg-Gly-Asp-containing disintegrins.
• Analysis of tyrosine phosphorylation of platelet proteins, including pp72syk and pp125FAK.
• Assessment of platelet shape change, secretion, and aggregation.

Main Results:

• Dimeric contortrostatin, but not monomeric multisquamatin, triggered tyrosine phosphorylation of pp72syk and a 140-kDa protein, mimicking fibrinogen cross-linking.
• Both contortrostatin and multisquamatin inhibited platelet aggregation and aggregation-dependent tyrosine phosphorylation of proteins like pp125FAK.
• Neither disintegrin affected thrombin-induced platelet shape change, secretion, or integrin-independent tyrosine phosphorylation.

Conclusions:

• Structurally distinct disintegrins exhibit varying effects on platelet tyrosine phosphorylation.
• Contortrostatin possesses a unique ability to activate intracellular signaling pathways leading to tyrosine phosphorylation, in addition to inhibiting aggregation.
• These findings suggest a potential role for contortrostatin in hemostasis through modulation of platelet signaling and aggregation.